Not all clients with CLL require therapy. In spite of all new advances, the iwCLL nonetheless suggests watchful observation for sufferers with asymptomatic sickness.86 This advice is based on a minimum of two randomized trials comparing observation to both chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR). Anda pasti harus https://harlanm429nhr4.cosmicwiki.com/user